^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ETH-155008

    i
    Associations
    News
    Trials
    Company:
    Shengke Pharmaceuticals
    Drug class:
    PIM-1 inhibitor
    Related drugs:
    Associations
    News
    Trials